News & Updates

Miso, natto suppress CVD risk in women

19 Jun 2021

Fermented soy products may help reduce the risk of cardiovascular diseases (CVDs), especially in women, a recent Japan study has found.

Miso, natto suppress CVD risk in women

19 Jun 2021

Handgrip strength conveys hypertension risk in adults

18 Jun 2021

Middle-aged and older individuals with high weight-adjusted handgrip strength are at low risk of developing hypertension, a study suggests.

Handgrip strength conveys hypertension risk in adults

18 Jun 2021

Left atrial appendage occlusion may reduce ischaemic stroke risk in AF

17 Jun 2021 by

Left atrial appendage occlusion (LAAO) added to usual care led to a reduction in ischaemic stroke or non-cerebral systemic embolism following cardiac surgery among patients with atrial fibrillation (AF), according to results of the LAAOS* III trial.

Left atrial appendage occlusion may reduce ischaemic stroke risk in AF

17 Jun 2021

Atorvastatin: Is there evidence of benefit in COVID-19?

17 Jun 2021 by

Treatment with the HMG-CoA reductase inhibitor atorvastatin in critically ill patients with COVID-19 did not significantly reduce the primary composite outcome of venous or arterial thrombosis risk, treatment with extracorporeal membrane oxygenation (ECMO), or mortality vs placebo in the INSPIRATION-S study presented at ACC.21.

Atorvastatin: Is there evidence of benefit in COVID-19?

17 Jun 2021

Early diabetic polyneuropathy signals subsequent CVD

17 Jun 2021

Among patients with newly diagnosed type 2 diabetes, the risk of developing cardiovascular disease (CVD) is elevated in the presence of symptoms indicative of diabetic polyneuropathy, as shown in a study.

Early diabetic polyneuropathy signals subsequent CVD

17 Jun 2021

Minority of SIHD patients undergoing PCI meet ISCHEMIA trial criteria

15 Jun 2021 by

Only a small fraction of patients with stable ischaemic heart disease (SIHD) who undergo percutaneous coronary intervention (PCI) in the US meet the inclusion criteria of the ISCHEMIA* trial, according to results of a study presented at SCAI 2021.

Minority of SIHD patients undergoing PCI meet ISCHEMIA trial criteria

15 Jun 2021

Original New Drug Application Approvals by US FDA (01 - 15 June 2021)

15 Jun 2021

New drug applications approved by US FDA as of 01-15 June 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 June 2021)

15 Jun 2021

Short-term LDL-C change translates to reductions in long-term MACE risk

14 Jun 2021

In patients with acute coronary syndromes, undergoing a more intensive low-density lipoprotein cholesterol (LDL-C)–lowering therapy during the early disease phase leads to a significant decrease in the risk of long-term major adverse cardiac events (MACEs), according to a study. This benefit is more pronounced for patients with higher baseline and larger reduction in LDL-C levels.

Short-term LDL-C change translates to reductions in long-term MACE risk

14 Jun 2021

GVHD severity, donor-recipient blood type impact thromboembolic event risk

13 Jun 2021

In patients who develop chronic graft-versus-host disease (cGVHD) after haematopoietic cell transplantation (HCT), the risk of thromboembolic events (TEE) seems to be affected by disease severity and donor-recipient ABO blood group, a recent study has found.

GVHD severity, donor-recipient blood type impact thromboembolic event risk

13 Jun 2021

Maternal stroke history tied to haemorrhagic stroke risk in T1D patients

13 Jun 2021

Patients with type 1 diabetes (T1D) born to mothers with a history of stroke are at heightened risk of developing haemorrhagic stroke, a study reports.

Maternal stroke history tied to haemorrhagic stroke risk in T1D patients

13 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

Miso, natto suppress CVD risk in women

Miso, natto suppress CVD risk in women

Handgrip strength conveys hypertension risk in adults

Handgrip strength conveys hypertension risk in adults

Left atrial appendage occlusion may reduce ischaemic stroke risk in AF

Left atrial appendage occlusion may reduce ischaemic stroke risk in AF

Atorvastatin: Is there evidence of benefit in COVID-19?

Atorvastatin: Is there evidence of benefit in COVID-19?

Early diabetic polyneuropathy signals subsequent CVD

Early diabetic polyneuropathy signals subsequent CVD

Minority of SIHD patients undergoing PCI meet ISCHEMIA trial criteria

Minority of SIHD patients undergoing PCI meet ISCHEMIA trial criteria

Original New Drug Application Approvals by US FDA (01 - 15 June 2021)

Original New Drug Application Approvals by US FDA (01 - 15 June 2021)

Short-term LDL-C change translates to reductions in long-term MACE risk

Short-term LDL-C change translates to reductions in long-term MACE risk

GVHD severity, donor-recipient blood type impact thromboembolic event risk

GVHD severity, donor-recipient blood type impact thromboembolic event risk

Maternal stroke history tied to haemorrhagic stroke risk in T1D patients

Maternal stroke history tied to haemorrhagic stroke risk in T1D patients